Medtech giant Medtronic has successfully seen two patents for its sacral neuromodulation (SNM) upheld before US courts, opening the way for a lawsuit against bladder and bowel company Axonics.

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a unanimous verdict in a patent infringement lawsuit brought by larger rival ...

including as a result of the Medtronic Litigation; introductions and announcements of new technologies by Axonics, any commercialization partners or Axonics’ competitors, and the timing of these ...

Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...

IRVINE, Calif., September 18, 2024--Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic has received Food and Drug Administration approval to study its Affera mapping and ablation ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial ...